Because microglial activation can cause both neuronal excitotoxicity and neuroinflammation, attenuation of microglial activity represents a promising avenue to ameliorate post-HCA injury.
TLRs play an important role in the regulation of microglial activity during gliomagenesis.
Activation of microglia has been implicated in various neurodegenerative disorders, and thus the inhibition of microglial activity may suppress these disorders.
The TSPO is a sensitive and robust biomarker of microglial activity in the CNS.
By contrast, TNF- α production and GR translocation to the nucleus reflect more complex roles of microglial activity.
Our data indicate a general increase of microglial activity and immune responses, likely aggravating ALS disease symptoms.
Neuroinflammation could be reduced through direct inhibition of brain mast cells and modulation of microglial activity via disruption of the SCF/c-Kit signalling pathway [ 15, 23].
However, (R -[11C]PK11195 has seveR -[11C]PK11195, including its low signal-to-noise ratio, hashly variable kineticseveralapparent limitationssincludingor detectits low levels of microglial activation.
Assessment of the level of microglial phagocytosis activity, quantified as the density of phagocytosed ONL nuclei (Fig 3D) and the mean number of phagocytosed nuclei per infiltrating microglia (Fig 3E), demonstrated a peak at P21 before decreasing thereafter.
However, no clear consensus defines the overall level of microglial phagocytosis in the human AD brain.
